Primerica (NYSE:PRI - Get Free Report) released its quarterly earnings results on Tuesday. The financial services provider reported $5.03 EPS for the quarter, topping analysts' consensus estimates of $4.81 by $0.22, Zacks reports. Primerica had a net margin of 14.95% and a return on equity of 30.93%.
Primerica Price Performance
Primerica stock traded down $2.85 during trading hours on Friday, reaching $281.29. The stock had a trading volume of 134,291 shares, compared to its average volume of 141,950. The company has a market cap of $9.39 billion, a price-to-earnings ratio of 21.49 and a beta of 1.11. The business's 50 day moving average price is $282.45 and its 200-day moving average price is $275.52. Primerica has a 52 week low of $184.76 and a 52 week high of $307.91.
Primerica Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Friday, February 21st will be given a dividend of $1.04 per share. This represents a $4.16 annualized dividend and a yield of 1.48%. The ex-dividend date is Friday, February 21st. This is a boost from Primerica's previous quarterly dividend of $0.90. Primerica's dividend payout ratio (DPR) is 30.25%.
Primerica declared that its Board of Directors has approved a share buyback program on Thursday, November 14th that permits the company to repurchase $450.00 million in shares. This repurchase authorization permits the financial services provider to purchase up to 4.5% of its stock through open market purchases. Stock repurchase programs are usually a sign that the company's board believes its stock is undervalued.
Analyst Upgrades and Downgrades
PRI has been the subject of a number of research analyst reports. Truist Financial raised their price target on Primerica from $300.00 to $340.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. TD Cowen upped their price target on shares of Primerica from $314.00 to $345.00 and gave the stock a "buy" rating in a report on Tuesday, November 26th. Piper Sandler cut their price target on shares of Primerica from $313.00 to $300.00 and set a "neutral" rating on the stock in a report on Wednesday, December 18th. BMO Capital Markets initiated coverage on shares of Primerica in a report on Thursday, January 23rd. They issued a "market perform" rating and a $311.00 price target on the stock. Finally, Morgan Stanley upped their price target on shares of Primerica from $308.00 to $313.00 and gave the stock an "equal weight" rating in a report on Friday. Six investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, Primerica currently has an average rating of "Hold" and an average price target of $310.43.
Read Our Latest Research Report on Primerica
Primerica Company Profile
(
Get Free Report)
Primerica, Inc, together with its subsidiaries, provides financial products and services to middle-income households in the United States and Canada. The company operates in four segments: Term Life Insurance; Investment and Savings Products; Senior Health; and Corporate and Other Distributed Products.
Featured Articles

Before you consider Primerica, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Primerica wasn't on the list.
While Primerica currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.